Utilizing systematic Mendelian randomization to identify potential therapeutic targets for mania.

Area of Science:

• Genetics
• Pharmacology
• Bioinformatics

Background:

• Mania imposes significant economic and social burdens.
• Current treatments for mania lack efficacy and are associated with side effects.

Purpose of the Study:

• To identify potential drug target genes and key substances for mania treatment.
• To explore the mRNA level associations and causal relationships.

Main Methods:

• Utilized bioinformatics and two-sample Mendelian randomization (MR).
• Analyzed gene expression profiles from the GEO database.
• Employed eQTL and mania GWAS data from the IEU database for colocalization analysis.

Main Results:

• Identified a causal relationship between 46 genes and mania.
• Six core genes were determined through colocalization analysis.
• Discovered phenylalanine as a key substance with a unidirectional causal relationship with mania.
• Identified SBNO2, PBX2, RAMP3, and QPCT as potential drug target genes linked to phenylalanine metabolism.

Conclusions:

• SBNO2, PBX2, RAMP3, and QPCT are promising therapeutic targets for mania.
• Targeting phenylalanine metabolism via these genes offers a potential treatment strategy.
• Further research is warranted to validate these findings in clinical settings.